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Abstract: Background: Angiodysplasia of the gastrointestinal 
tract is an uncommon, but not rare, cause of bleeding and 
severe anemia in elderly. Different treatments exist for this 
kind of pathology.
Methods: The aim of this work was to study 40 patients 
treated for intestinal angiodysplasia with two different 
kind of endoscopic treatments: argon plasma coagulation 
(APC) and bipolar electrocoagulation (BEC). 
Results: Age of patients was similar in both groups (76,2 
± 10.8 years vs 74,8 ± 8,7 years, P = 0,005). Angiodysplasia 
treated were located in small bowel, right colon, left 
colon, transverse colon and cecum. We analysed number 
of treatment, recurrence, hospital discharge, needs of 
blood transfusions before and after endoscopic treatment. 
Number of treatment was the same in both groups (1,2 
± 0,2 vs 1,1 ± 0,1, P < 0,001). We had more recurrence in 
patients treated with BEC (4/20 vs 2/20, P < 0,001). Hospital 
discharge was comparable in both groups (5,3 ± 3,1 days vs 
5,4 ± 2,8 years, P < 0.001)
Conclusions: Treatment of angiodysplasia in elderly is 
not easy. Different kinds of treatment could be adopted. 
APC and BEC are both safe and effective. The choice 
of a treatment should consider several factors: age, 
comorbidity, source of bleeding. In conclusion we think 
that treatment of bleeding for angiodysplasia in elder 
population should be a tailored treatment.
Keywords: Angiodysplasia, Elderly, Bleeding, Tailored, 
Argon plasma coagulation
1 Introduction
Blood loss from the lower digestive tract is a common 
problem. Frequently angiodysplasias orarteriovenous 
malformations are cause of bleeding. Angiodysplasias 
or arteriovenous malformations are mainly found in the 
small bowel, especially in the lower ileum [1-4]. Most of 
Angiodysplasia lesions are restricted to the right colon but 
lesions spread throughout the upper, lower and middle 
gastrointestinal tract are present in one-third of cases [5-10]. 
Angiodysplasia can be asymptomatic and discovered 
incidentally during colonoscopy. Patients may present 
with hematochezia, melena, positive occult blood test or 
iron deficiency anemia. Angiodysplasia may present as 
an isolated lesion or multiple vascular lesions. The exact 
cause of vascular ectasia is not known but it is thought 
to occur due to ageing and degeneration of blood vessels 
[11-13]. Angiodysplasia is thought to result from chronic, 
intermittent, low-grade obstruction of submucosal veins. 
It may also be a complication of decreased mucosal blood 
flow and local ischemia. Most lesions are found in the 
cecum and ascending colon possibly due to increased 
wall tension of the right colon, but angiodysplasia can 
be found throughout the gastrointestinal tract. Patients 
withangiodysplasia are usually older than 60 years of age, 
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with a more than 200 fold increase in incidence between 
the third and ninth decades of life. This increased 
incidence with age supports the theory that acquired 
angiodysplasias are due to degenerative changes [14-27].
Most colonic angiodyplasia are diagnosed by 
endoscopy. Colonoscopy has a sensitivity of greater than 
80% when the entire colon is examined. Endoscopic 
therapy for bleeding angiodysplasia is successful, using 
a variety of treatment modalities. Therapy is generally 
indicated only when there is evidence of blood loss or 
active bleeding from a lesion and not for incidentally 
found, asymptomatic angiodysplasia [18-20].
2 Methods
In our Department of General Surgery, University of 
Naples “Federico II” we treated 40 patients affected 
by gastrointestinal angiodysplasia from March 2009 
to March 2013. All of them were symptomatic, with 
gastrointestinal bleeding due to angiodysplasia. Out of 
these 40 patients [mean age 75 year (65-85year)] 17 were 
male and 23 were female. We performed two kind of 
endoscopic treatment: Argon Coagulation Therapy (APC) 
and Bipolar Electrocoagulation (BEC). Argon plasma 
coagulation (APC) allows an efficient coagulation without 
any contact with gastrointestinal (GI)  tissues. Argon ions 
bring current to the tissues without any contact; in this 
way energy reach directly the angiodysplastic lesion. 
The power of coagulation is not deep (0.5–3mm) so we 
can reduce perforation risk (<0.5%) [14]. We use those 
power setup for different tissues:right colon, and small 
bowel: 0.6 L/min, 40W; left colon: 1 L/min, 60 W [12-16]. 
An other technique is bipolar electrocoagulation (BEC), 
in this system we have two electrodes, where on one side 
the electrode produces the coagulation current on the 
other side the opposite electrode is a receptor. In this way 
current does not need to pass through the human body 
[15-18].To perform coagulation we need to continue the 
contact between the bleeding vessel and our probe for 
sufficient time with enough power. The probe have to be 
in touch at 180° (tangential) with the lesion. 15 and 30 
W is the correct power to treat bleeding vessels, power 
depends by the site. We need also 3–4 applications for 
7–10 s. If current get in touch with the GI mucosa, we can 
modify its power and directly treat GI wall, f.e. for the right 
colon 5-20 W are necessary. Bipolar electrocoagulation is 
consider quite safe about tissue penetration risk.
Ethical approval: The research related to human 
use has been complied with all the relevant national 
regulations, institutional policies and in accordance the 
tenets of the Helsinki Declaration, and has been approved 
by the authors’ institutional review board or equivalent 
committee.
Informed consent: Informed consent has been 
obtained from all individuals included in this study.
3 Results and Discussion
We studied a group of elder patients affected by 
angiodysplasia (age between 65 and85 year). Exclusion 
criteria were: participant’s age < 65 year and > 85 year, 
neoplasms, end stage renal disease, cardiac failure. 
Patients were divided into two groups. First one was 
treated with Argon Plasma coagulation (APC), the second 
was treated with bipolar electrocoagulation (BEC).
Table 1 shows main characteristics of our patients. 
Age was similar in both groups (76,2 ±  10,8 vs 74,8 ± 8,7, 
P = 0,005). 12 males and 8 females in first group, 11 males 
and 9 females in second group (P = 0,875). Phrotrombin 
time was 11,4 ± 1,3 in the group of patients treated with 
APC, 11,2 ± 1,5 in BEC group (P = 0,555). APTT (full form) 
was 30,9 ± 6,1 in APC group, 28,2 ± 2,6 in BEC group 
(P = 0,088). Hb (full form) was 9,5 ± 2,1 in the first group 
of patients, 9,3 ± 1,9 in the second group (P = 0,612). Four 
patients treated with APC and two treated with BEC were 
affected by hepatic cirrhosis. Diagnosis was recognized 
with colonoscopy and enteroscopy. Sources of bleeding 
were different for each group. Patients treated with argon 
plasma coagulation: 5 right colon (25%), 5 left colon (25%), 
2 transverse colon (5%), 4 cecum (20%), 5 small bowel 
(25%). Patients treated with bipolar electrocoagulation: 
4 right colon (20%), 5 left colon (25%), 2 transverse colon 
(10%), 1 cecum (5%), 8 small bowel (40%).
Table 2 shows results of evaluated parameters. First of 
all, number of treatments required was clinically similar 
for both groups. In  APC group 1,2 ± 0,2, in BEC group 
1,1 ± 0,1 (P < 0,001). Most of patients needed one cycle of 
therapy to have a good control of bleeding. Patients treated 
with argon plasma coagulation had 10 % of recurrence 
(2/20), versus patients treated with bipolar electro 
coagulation who had 20 % of recurrence (4/20). So BEC 
shows a higher value of recurrence (P < 0,001). Generally 
a patient with bleeding for angiodysplasia need a good 
evaluation pre and post treatment with a complete control 
of blood chemistry and coagulation. After a complete 
resolution of all parameters, patients can be discharged. 
Considering hospital discharge in our study, comparison 
of two groups of patients shows clinically similar values. 
Patients treated with APC had a recovery of 7,3 ± 3,1 days. 
In the other group, patients were discharged after 
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6,8 ± 2,8 days(P < 0,001). In fact most of patients affected 
by angiodysplasia need transfusions and  a complete 
evaluation of blood test results is necessary. Finally 
considering the blood transfusion, pre and post treatment, 
five patients treated with APC needed  blood transfusion 
before treatment, two of them needed  transfusion also 
after the treatment. In the BEC group, four patients needed 
a blood transfusion before endoscopic treatment, two of 
them needed blood transfusion also after the treatment. 
So we had clinically comparable values also for these 
elements. The evaluation of the parameters analyzed 
shows that both treatments are safe and effective. The 
patients had a good response to treatment and recovery 
took place quickly. We believe that the choice of a treatment 
should be “tailored”. A good evaluation of the patient is 
always  important before treatment. Choice of treatment 
should be based on patient characteristics. The main 
factors to consider are definitely the age, comorbidities, the 
source of bleeding, the amount of bleeding. However these 
two treatments can be used to solve the bleeding caused 
by this type of vascular malformation. Elder population 
shows a good response to the endoscopic treatment.
4 Statistical analysis
Standard deviation (SD) and mean are used for continues 
dataMann–Whitney U test was used to analyzed 
continuous variables. Chi-square test or Fisher’s exact 
test were used for continuous data, which were reported 
in totals and percentage. Recurrent bleeding after APC 
treatment was studied using univariate and multivariate 
logistic regression. P value less than 0.05 is considered 
statistically significant. All statistical analyses were 
performed in SPSS 17.0 (SPSS, Inc., Chicago, IL, USA).
5 Conclusions
Treatment of angiodysplasia in elderly is not easy. Different 
kinds of treatment could be adopted. Argon plasma 
Table 1: 
Patients’  characteristics APC (n = 20) BEC (n = 20) P
Age 76,2 ± 10.8 years 74,8 ± 8,7 years 0,005
Gender (Male/Female) 12/8 11/9 0,875
Prothrombin time 11,4 ± 1,3 11,2 ± 1,5 0,555
APTT 30,9 ± 6,1 28,2 ± 2,6 0,088
Hb 9,5 ± 2,1 9,3 ± 1,9 0,612
Cirrhosis 4/20 (20%) 2/20 (10%) 0,442
Source of bleeding n/N (%)
Small Bowel 5/20 (25%) 8/20 (40%)
Right colon 5/20 (25%) 4/20 (20%)
Left colon 5/20 (25%) 5/20 (25%)
Transverse colon 1/20 (5%) 2/20 (10%)
Cecum 4/20 (20%) 1/20 (2%)
APC: Argon plasma coagulation, BEC: bipolar electro coagulation
Table 2: 
Study variables APC (n = 20) BEC (n = 20) P
Number of treatment 1,2 ± 0,2 1,1 ± 0,1 < 0,001
Recurrence n (%) 2 (10 %) 4 (20 %) < 0,001
Hospital discharge (day) 7,3 ± 3,1 6,8 ± 2,8 < 0,001
Blood transfusions before 
treatment n (%)
5 (25%) 4 (20%) < 0,001
Blood transfusions
after treatment n (%)
2 (10%) 2 (10 %) < 0,001
APC: Argon plasma coagulation, BEC: bipolar electro coagulation
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coagulation and bipolar electro coagulation are both safe 
and effective. The choice of a treatment should consider 
several factors: age, comorbidity, source and amount of 
bleeding. In conclusion we suggest a tailored treatment of 
bleeding for angiodysplasia in elder population, according 
to the main characteristics of patients [28-37].
Conflict of interest statement: Authors state no conflict 
of interest.
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